Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-11-022379
Filing Date
2011-03-07
Accepted
2011-03-07 06:01:23
Documents
14
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K f58478e10vk.htm 10-K 1836027
2 EX-10.41 f58478exv10w41.htm EX-10.41 6116
3 EX-10.42 f58478exv10w42.htm EX-10.42 2902
4 EX-14.1 f58478exv14w1.htm EX-14.1 25321
5 EX-23.1 f58478exv23w1.htm EX-23.1 1513
6 EX-31.1 f58478exv31w1.htm EX-31.1 7458
7 EX-31.2 f58478exv31w2.htm EX-31.2 7732
8 EX-32.1 f58478exv32w1.htm EX-32.1 2811
9 EX-32.2 f58478exv32w2.htm EX-32.2 2574
10 GRAPHIC f58478f5847801.gif GRAPHIC 38726
11 GRAPHIC f58478f5847802.gif GRAPHIC 4603
12 GRAPHIC f58478f5847803.gif GRAPHIC 12354
13 GRAPHIC f58478f5847804.gif GRAPHIC 6590
14 GRAPHIC f58478f5847805.gif GRAPHIC 9881
  Complete submission text file 0000950123-11-022379.txt   1993637
Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Filer) CIK: 0001316175 (see all company filings)

EIN.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34637 | Film No.: 11666571
SIC: 2834 Pharmaceutical Preparations